Dr Brian Bergmark, Brigham and Women’s Hospital Boston, USA, reports efficacy and safety data from the recently published BRIDGE-TIMI 73a trial of olezarsen, in hypertriglyceridaemia and elevated cardiovascular risk.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
